Drug Shortage Report for FOQUEST
| Report ID | 151791 |
| Drug Identification Number | 02470357 |
| Brand name | FOQUEST |
| Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
| Company Name | ELVIUM LIFE SCIENCES |
| Market Status | MARKETED |
| Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N06BA |
| ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-01-07 |
| Actual start date | 2022-01-05 |
| Estimated end date | 2024-12-06 |
| Actual end date | 2024-11-25 |
| Shortage status | Resolved |
| Updated date | 2024-11-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v177 | 2024-11-26 | English | Compare |
| v176 | 2024-11-25 | French | Compare |
| v175 | 2024-11-25 | English | Compare |
| v174 | 2024-11-07 | French | Compare |
| v173 | 2024-11-07 | English | Compare |
| v172 | 2024-10-29 | French | Compare |
| v171 | 2024-10-29 | English | Compare |
| v170 | 2024-10-15 | French | Compare |
| v169 | 2024-10-15 | English | Compare |
| v168 | 2024-09-16 | French | Compare |
| v167 | 2024-09-16 | English | Compare |
| v166 | 2024-06-24 | French | Compare |
| v165 | 2024-06-24 | English | Compare |
| v164 | 2024-05-31 | French | Compare |
| v163 | 2024-05-31 | English | Compare |
| v162 | 2024-05-24 | French | Compare |
| v161 | 2024-05-24 | English | Compare |
| v160 | 2024-05-13 | French | Compare |
| v159 | 2024-05-13 | English | Compare |
| v158 | 2024-05-13 | English | Compare |